EU Horizon funding · NACE 21.20
Horizon Europe funding for pharmaceutical preparations manufacturing companies
NACE 21.20 · Manufacture of pharmaceutical preparations
31 pharmaceutical preparations manufacturing companies (NACE 21.20) received €66M in EU research and innovation funding across 104 Horizon Europe and Horizon 2020 projects starting between 2014 and 2027; 26% of the money went to SMEs.
- EU contribution
- €66M
- 2014–2027 project starts
- Funded companies
- 31
- 13 of them SMEs
- Projects
- 104
- Horizon Europe and Horizon 2020
- Share to SMEs
- 26%
- €17M to SMEs
Industry is known only for companies matched to the national business registers in France, Finland, Belgium, Estonia, Sweden and Czech Republic, so this page covers funded private companies from those countries. Companies elsewhere in Europe are counted on the country pages.
In numbers
Of the total, Horizon 2020 (2014–2020) accounts for €39M across 59 projects and Horizon Europe (2021–2027) for €26M across 45 projects.
The strongest start year was 2014, when projects worth €14M to these companies began.
The largest funding route was the Research and Innovation Action (RIA) with €38M (57% of the total, 43 projects). The SME Instrument Phase 2 added €5M for 1 project.
AstraZeneca AB (Södertälje) is the largest recipient with €15M over 37 projects; the 10 largest recipients together received 90% of the total.
The average funded company received €2.1M; 42% of the companies are SMEs.
By programme
Horizon 2020 2014–2020
€39M
59 projects · 60% of the total
Horizon Europe 2021–2027
€26M
45 projects · 40% of the total
Funding by start year
EU contribution to these companies, by the year their project started.
| Year | EU contribution |
|---|---|
| 2014 |
€14M
|
| 2015 |
€6.5M
|
| 2016 |
€2.7M
|
| 2017 |
€3.3M
|
| 2018 |
€1.1M
|
| 2019 |
€4.7M
|
| 2020 |
€2.6M
|
| 2021 |
€4.3M
|
| 2022 |
€4.1M
|
| 2023 |
€6.5M
|
| 2024 |
€2.1M
|
| 2025 |
€3.8M
|
| 2026 |
€9.6M
|
| 2027 |
€325k
|
2014–2020 starts (mostly Horizon 2020) 2021 onwards (Horizon Europe)
Largest recipients
Companies with the highest EU contribution, Horizon Europe and Horizon 2020 combined.
| # | Company | Programmes | Projects | EU contribution |
|---|---|---|---|---|
| 1 | AstraZeneca AB Södertälje, Sweden | Horizon 2020, Horizon Europe | 37 | €15M |
| 2 | GlaxoSmithKline Biologicals Rixensart, Belgium | Horizon 2020 | 1 | €14M |
| 3 | Janssen Pharmaceutica Beerse, Belgium | Horizon 2020, Horizon Europe | 27 | €9.5M |
| 4 | NorthX Biologics AB SME Matfors, Sweden | Horizon 2020, Horizon Europe | 3 | €8.5M |
| 5 | Firalis Molecular Precision SME Huningue, France | Horizon 2020 | 1 | €5M |
| 6 | Quantoom Biosciences Nivelles, Belgium | Horizon Europe | 3 | €2.8M |
| 7 | Obulytix Gent, Belgium | Horizon Europe | 1 | €1.5M |
| 8 | Adhexpharma Paris, France | Horizon 2020, Horizon Europe | 2 | €1.2M |
| 9 | StemSight Oy SME Tampere, Finland | Horizon Europe | 2 | €1.2M |
| 10 | FinVector Oy Kuopio, Finland | Horizon 2020 | 2 | €857k |
Funding schemes
How the money reached these companies.
-
Research and Innovation Action (RIA) €38M43 projects HORIZON-RIA · RIA 57%
-
Marie Skłodowska-Curie Actions €16M42 projects HORIZON-TMA-MSCA-DN · HORIZON-TMA-MSCA-DN-ID · HORIZON-TMA-MSCA-SE 24%
-
SME Instrument Phase 2 €5M1 project SME-2 8%
-
Innovation Action (IA) €3.8M9 projects HORIZON-IA · IA 6%
-
Joint Undertaking actions (Horizon Europe) €1.5M1 project HORIZON-JU-RIA 2%
-
EIC Pathfinder & Transition €1.4M3 projects HORIZON-EIC 2%
Notable recent projects
Recent projects with the largest EU contribution to these companies. Links open the project on CORDIS.
-
THANATOS
THERAPEUTIC ANTIBODIES NEUTRALIZING ALL THE ORTHOPOXVIRUS INFECTIOUS FOR HUMANS, INCLUDING SMALLPOX
Started 2026 Horizon Europe Research and Innovation Action (RIA) Total EU contribution €14M to these companies €4.9M
-
HENIPROTECT
EU-HENIpavirus PROTECTion via inhaled antibody solution
Started 2026 Horizon Europe Research and Innovation Action (RIA) Total EU contribution €16M to these companies €2.3M
-
END2AMR
European Novel Drug research to Address Microbial infections and drug Resistance
Started 2026 Horizon Europe Joint Undertaking actions (Horizon Europe) Total EU contribution €15M to these companies €1.5M
-
KeratOPrinter
Advanced 4D Printing Technologies in Corneal Regeneration: A Pathway to Restored Vision
Started 2025 Horizon Europe Research and Innovation Action (RIA) Total EU contribution €8M to these companies €1.1M
-
NAP4DIVE
Non-Animal Platform for Nanoparticle-Based Delivery across the blood-brain barrier Interface with Vehicle Evolution
Started 2025 Horizon Europe Research and Innovation Action (RIA) Total EU contribution €7.8M to these companies €871k
Get company lists in Claude
Ask Claude for companies by industry, size and region, straight from official European business registers, and export the list as CSV.
Source and method
Source: CORDIS – © European Union, 1994–2026, CC BY 4.0. Data modified: aggregated by EU Company Leads. Project and participant data from CORDIS (Horizon Europe and Horizon 2020 project datasets), licensed under CC BY 4.0.
We count organisations that CORDIS lists as private for-profit companies (activity type PRC) with an EU contribution above zero. Amounts are the EU contribution to those companies, not total project budgets; years are project start years. Industries use NACE Rev. 2.1 from the national business registers of France, Finland, Belgium, Estonia, Sweden and Czech Republic and are only known for companies matched to those registers. Figures computed Nov 17, 2026.